Repligen Corporation v. Canada (Attorney General) 2012 FC 931 Near J
Repligen’s former patent agent transposed two digits of Repligen’s patent 1,341,486, to
1,314,486, when it engaged Computer Patent Annuities to pay maintenance fees on the patent.
Consequently, the fees were paid against the “14" patent, which was held by Rolls-Royce.
Sometimes the fees would be paid first on behalf of Rolls-Royce, sometimes on behalf of
Repligen. The second payor would to be told that fees had already been paid and would request a
refund. While duplicate fees were paid on the "14" patent, no fees were paid on Repligen’s “41" patent and CIPO sent a Maintenance Fee Notice
to Repligen’s former agent advising that the patent would lapse unless payment was made within
twelve months. Repligen’s former agent did not respond [5], and the “41" patent lapsed.
Repligen then switched agents. Its new agent attempted to have the patent reinstated, arguing
that the Commission should exercise her discretion to correct the clerical error under s 8 of the
Act and reinstate the patent. The Commissioner refused, primarily on the basis of the lengthy
delay and the potential for prejudice to third parties who might have relied on the register
showing the patent as lapsed [#1 59].
In Repligen #1 2010 FC 1288 Lemieux J held that the Commissioner had not properly exercised
her discretion. A crucial point was that the Commissioner’s concern regarding prejudice to third
parties was speculative as she had no evidence of third party prejudice. Lemieux J contrasted this
with Bristol-Meyers (1998), 82 C.P.R. (3d) 192 (FCA) in which two other companies had filed
priority claims for similar drugs [#1 60(f)]. Lemieux J noted the “catastrophic consequences” of
the loss of patent rights [#1 59], and insisted that the Commissioner take into account the impact
on Repligen in deciding whether the patent should be reinstated [#1 60(a)].
I am inclined to think that the Commissioner was right on this point. There may be many cases in
which a third party would have relied on the lapse of the patent in a way that could not come to
the attention of the Commissioner. For example a third party might have done patent clearance search before
deciding to invest in developing a new product and then proceeded after having determined that its
product would infringe the Repligen patent, but that the patent had lapsed. Given the nature of third
party rights, it seems likely that it would be only in relatively unusual circumstances, such as
those in Bristol-Meyers, that the Commissioner could become aware of the prejudice to third
parties. It is true that the consequences to Repligen of the loss of its patent rights can be
catastrophic, but it is also true that infringement of those rights could be catastrophic to a third
party.
In any event, this was not the view of Lemieux J, who remitted the matter to be reconsidered by a
different official in the Patent Office. The Commissioner once again refused to correct the error,
and Repligen once again sought judicial review, leading to this decision in Repligen #2. This
time the Commissioner focused on potential prejudice to Rolls-Royce. The Commissioner argued
that “‘[c]orrecting Repligen's error today could retroactively have the effect of causing the
Rolls-Royce patent to have expired in 2008' since the payments originally applied to it would
automatically turn over to the Repligen Patent” [# 2 16]. Near J rejected this argument, rightly in
my view. Fees were always paid in respect of Rolls-Royce’s patent, which never lapsed and has
now expired [# 2 31]. I see this argument by the Commissioner as a way of attempting to point
to an actual prejudice rather than a speculative prejudice in order to satisfy the direction by
Lemieux J. It is an unsatisfactory attempt, as the Commissioner identified the real issue correctly
in the first instance; the real question is whether the Commissioner should consider harm to third
parties who may have relied on the lapse, unbeknownst to the Commissioner. Lemieux J, and
now Near J, have held that it should not.
The matter had been remitted to the Patent Office once again. Even if the patent is reinstated, I
am not sure Repligen’s troubles are over. Loss of patent rights is not “catastrophic” if those rights
are never exercised. But if Repligen has the patent reinstated and then brings an infringement
action against a competitor who can show that it did in fact rely on the lapsed patent, there is a a
very strong argument that that defendant should have some kind of equitable defence. If the
defendant can say “I searched for patents before undertaking my business, I found this patent that
I would have infringed, I determined that it had lapsed, and I then invested $10 million in
reliance on that,” it would be a serious failure of the patent system to allow Repligen to enforce
against that defendant.
No comments:
Post a Comment